Thomas Herdegen
Overview
Explore the profile of Thomas Herdegen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
2199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gastmeier K, Gastmeier A, Schwab F, Herdegen T
Med Cannabis Cannabinoids
. 2024 Apr;
7(1):59-67.
PMID: 38655402
Introduction: Tetrahydrocannabinol (THC) is often prescribed for ambulatory palliative patients to improve sleep quality and appetite and to reduce anxiety, stress, and pain. However, it is not known if THC...
2.
Herdegen T, Cascorbi I
Dtsch Arztebl Int
. 2023 Oct;
120(49):833-840.
PMID: 37874128
Background: Cannabinoid drugs containing tetrahydrocannabinol (THC), or its structural analogues, as monotherapeutic agents or as extracts or botanical preparations with or without cannabidiol (CBD) are often prescribed to multimorbid patients...
3.
Bohm R, Westermann P, Gleim M, Cascorbi I, Gruenewald M, Herdegen T, et al.
Eur J Pain
. 2021 Apr;
25(8):1739-1750.
PMID: 33909330
Background: Spironolactone (SPL) is a reversible mineralocorticoid receptor (MR) and androgen receptor (AR) antagonist which attracts pharmacotherapeutic interest not only because of its beneficial effects in heart failure but also...
4.
Bohm R, Bulin C, Waetzig V, Cascorbi I, Klein H, Herdegen T
Br J Clin Pharmacol
. 2021 Apr;
87(11):4421-4431.
PMID: 33871897
No abstract available.
5.
Zhao Y, Lutzen U, Gohlke P, Jiang P, Herdegen T, Culman J
J Mol Med (Berl)
. 2021 Apr;
99(8):1073-1083.
PMID: 33864097
The present study elucidates the neuroprotective mechanisms of the PPARγ (peroxisome proliferator-activated receptor γ) agonist pioglitazone in survival of ischemic neurons following middle cerebral artery occlusion with reperfusion (MCAO). Intracerebroventricular...
6.
Lorenzati M, Boda E, Parolisi R, Bonato M, Borsello T, Herdegen T, et al.
Sci Rep
. 2021 Apr;
11(1):7264.
PMID: 33790350
During Central Nervous System ontogenesis, myelinating oligodendrocytes (OLs) arise from highly ramified and proliferative precursors called oligodendrocyte progenitor cells (OPCs). OPC architecture, proliferation and oligodendro-/myelino-genesis are finely regulated by the...
7.
Helbig C, Weber F, Andreas N, Herdegen T, Gaestel M, Kamradt T, et al.
Sci Rep
. 2020 May;
10(1):8152.
PMID: 32424229
IL-33, an IL-1 cytokine superfamily member, induces the activation of the canonical NF-κB signaling, and of Mitogen Activated Protein Kinases (MAPKs). In dendritic cells (DCs) IL-33 induces the production of...
8.
Sanna M, Manassero G, Vercelli A, Herdegen T, Galeotti N
Eur J Pharmacol
. 2020 May;
880:173161.
PMID: 32416188
Nucleoside reverse transcriptase inhibitors (NRTIs) are associated with the development of painful neuropathies and may further aggravate sensory neuropathy produced by HIV-1 infection, leading to discontinuation of NRTI therapy by...
9.
Zingler G, Herdegen T
Ann Transl Med
. 2019 Jan;
6(Suppl 1):S36.
PMID: 30613611
No abstract available.
10.
Hahn-Godeffroy J, Mangold S, Bernert M, Bartelt A, Herdegen T
Complement Med Res
. 2018 Nov;
26(1):13-21.
PMID: 30476918
Hintergrund: Procain besitzt wie das strukturverwandte Cocain zentralnervöse Wirkungen unabhängig von seinem lokalanästhetischen Effekt. Procain-Infusionen werden Patienten mit psychovegetativen Störungen seit Jahrzehnten verabreicht, zumeist im Rahmen einer Neuraltherapie. Untersuchungen zur...